Later dose decisions depend on a consistent monitoring baseline
Choose Bpc-157 When Facing Tendon injuries including tennis elbow, golfers elbow, Achilles tendonitis, patellar tendinopathy, and rotator cuff issues Ligament damage especially partial tears and sprains Gastrointestinal problems including ulcers, IBD, IBS, gastritis, and leaky gut Need to protect tissues from corticosteroid damage Nerve tissue protection and neuroprotection applications Single localized injury requiring targeted repair Bpc-157 uniquely prevents corticosteroid damage to tendons, directly upregulates growth hormone receptors on tendon fibroblasts, and can be taken orally with maintained bioavailability for gut issues
Rat inferior caval vein (ICV) ligature and particular new insights with the stable gastric pentadecapeptide BPC 157
Tesamorelin (a component of the stack) Tesamorelin + Ipamorelin) is the only individual component with FDA approval, but only for its specific indication (HIV lipodystrophy, as monotherapy)
Quality of care and environment: You have the right to be treated with a professional standard of care, by appropriately qualified and experienced staff, in a properly approved or registered organisation that meets required levels of safety and quality
The case for caution The combination is untested
